Autologous Bone Marrow Transplantation for Multiple Myeloma
- 1 April 1992
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 6 (2) , 437-449
- https://doi.org/10.1016/s0889-8588(18)30355-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- VAD‐based regimens as primary treatment for multiple myelomaAmerican Journal of Hematology, 1990
- Management of multiple myelomaAnnals of Hematology, 1990
- INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSIONThe Lancet, 1989
- INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMAThe Lancet, 1989
- Chemotherapy of myeloma: Drug combinations versus single agents, an overview, and comments on acute leukemia in myelomaHematological Oncology, 1988
- HIGH DOSE MELPHALAN AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN HIGH RISK MYELOMABritish Journal of Haematology, 1987
- Multiple myeloma treated with high dose intravenous melphalanBritish Journal of Haematology, 1987
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983